Stock listing
OTC:OPHLY ONO Pharmaceutical Co., Ltd. Stock
US listing (OTC) of ONO Pharmaceutical Co., Ltd. · home listing Tokyo:4528
Follow ONO Pharmaceutical Co., Ltd. into a list and get an email when it puts out news.
Share price · OTC:OPHLY
$5.14 USD +0.01 (+0.2%)
Close on Nov 20, 2026
- Day range
- $5.14 – $5.22 USDNov 20, 2026
- Volume
- 200 sharesNov 20, 2026
- Market cap
- $7.25B USDAt the close on Nov 20, 2026 · price × 1.41B shares outstanding
- 52-week range
- $4.42 – $5.71 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $280,632 USDMedian day 40,384 shares · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| OTC:OPHLY | $5.14 USD | +0.01 (+0.2%) | 200 | $5.22 | $5.22 | $5.14 | $5.13 | Close on Nov 20, 2026 |
| Frankfurt:ON4 | €13.47 EUR | -0.13 (-1.0%) | — | €13.44 | €13.47 | €13.44 | €13.60 | Close on Nov 20, 2026 |
| Munich:ON4 | €13.72 EUR | -0.655 (-4.6%) | — | €14.05 | €14.05 | €13.72 | €14.37 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · OTC:OPHLY · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $4.91 | -0.20 | -3.9% | $4.92 | $4.97 | $4.91 | 39,200 | |
| $5.11 | +0.09 | +1.8% | $5.05 | $5.17 | $5.05 | 49,200 | |
| $5.02 | +0.23 | +4.8% | $4.97 | $5.02 | $4.97 | 69,400 | |
| $4.79 | -0.05 | -1.0% | $4.78 | $4.85 | $4.78 | 69,500 | |
| $4.84 | +0.13 | +2.8% | $4.69 | $4.94 | $4.69 | 30,300 | |
| $4.71 | +0.05 | +1.1% | $4.72 | $4.75 | $4.71 | 51,500 | |
| $4.66 | -0.52 | -10.0% | $4.81 | $4.85 | $4.66 | 27,200 | |
| $5.18 | +0.04 | +0.8% | $5.09 | $5.18 | $5.04 | 73,900 | |
| $5.14 | -0.10 | -1.9% | $5.19 | $5.22 | $5.13 | 79,300 | |
| $5.24 | -0.074 | -1.4% | $5.20 | $5.28 | $5.20 | 42,500 | |
| $5.314 | -0.022 | -0.4% | $5.314 | $5.314 | $5.314 | 40,596 | |
| $5.336 | +0.059 | +1.1% | $5.336 | $5.336 | $5.336 | 20,119 | |
| $5.277 | +0.041 | +0.8% | $5.277 | $5.277 | $5.277 | 22,612 | |
| $5.236 | +0.112 | +2.2% | $5.236 | $5.236 | $5.236 | 196,407 | |
| $5.124 | +0.028 | +0.5% | $5.124 | $5.124 | $5.124 | 135,497 | |
| $5.096 | +0.133 | +2.7% | $5.096 | $5.096 | $5.096 | 20,912 | |
| $4.963 | +0.209 | +4.4% | $4.963 | $4.963 | $4.963 | 68,369 | |
| $4.754 | -0.08 | -1.7% | $4.754 | $4.754 | $4.754 | 35,037 | |
| $4.834 | +0.089 | +1.9% | $4.834 | $4.834 | $4.834 | 82,825 | |
| $4.745 | -0.008 | -0.2% | $4.745 | $4.745 | $4.745 | 67,563 | |
| $4.753 | +0.019 | +0.4% | $4.753 | $4.753 | $4.753 | 37,660 | |
| $4.734 | -0.026 | -0.5% | $4.734 | $4.734 | $4.734 | 45,162 | |
| $4.76 | -0.035 | -0.7% | $4.76 | $4.76 | $4.76 | 19,217 | |
| $4.795 | -0.013 | -0.3% | $4.795 | $4.795 | $4.795 | 73,436 | |
| $4.808 | -0.033 | -0.7% | $4.808 | $4.808 | $4.808 | 41,705 | |
| $4.841 | -0.089 | -1.8% | $4.841 | $4.841 | $4.841 | 75,839 | |
| $4.93 | -0.048 | -1.0% | $4.93 | $4.93 | $4.93 | 85,279 | |
| $4.978 | +0.042 | +0.9% | $4.978 | $4.978 | $4.978 | 56,380 | |
| $4.936 | -0.162 | -3.2% | $4.936 | $4.936 | $4.936 | 31,890 | |
| $5.098 | -0.081 | -1.6% | $5.098 | $5.098 | $5.098 | 17,122 | |
| $5.179 | +0.129 | +2.6% | $5.179 | $5.179 | $5.179 | 39,387 | |
| $5.05 | +0.017 | +0.3% | $5.05 | $5.05 | $5.05 | 57,185 | |
| $5.033 | -0.03 | -0.6% | $5.033 | $5.033 | $5.033 | 239,681 | |
| $5.063 | +0.006 | +0.1% | $5.063 | $5.063 | $5.063 | 259,981 | |
| $5.057 | -0.002 | 0.0% | $5.057 | $5.057 | $5.057 | 69,424 | |
| $5.059 | -0.057 | -1.1% | $5.059 | $5.059 | $5.059 | 112,690 | |
| $5.116 | +0.109 | +2.2% | $5.116 | $5.116 | $5.116 | 17,977 | |
| $5.007 | -0.052 | -1.0% | $5.007 | $5.007 | $5.007 | 25,363 | |
| $5.059 | +0.023 | +0.5% | $5.059 | $5.059 | $5.059 | 14,723 | |
| $5.036 | -0.003 | -0.1% | $5.036 | $5.036 | $5.036 | 23,001 | |
| $5.039 | -0.036 | -0.7% | $5.039 | $5.039 | $5.039 | 36,963 | |
| $5.075 | -0.044 | -0.9% | $5.075 | $5.075 | $5.075 | 114,200 | |
| $5.119 | -0.128 | -2.4% | $5.119 | $5.119 | $5.119 | 40,172 | |
| $5.247 | +0.019 | +0.4% | $5.247 | $5.247 | $5.247 | 38,913 | |
| $5.228 | -0.113 | -2.1% | $5.228 | $5.228 | $5.228 | 32,115 | |
| $5.341 | +0.153 | +2.9% | $5.341 | $5.341 | $5.341 | 24,788 | |
| $5.188 | +0.013 | +0.3% | $5.188 | $5.188 | $5.188 | 30,519 | |
| $5.175 | +0.06 | +1.2% | $5.175 | $5.175 | $5.175 | 51,661 | |
| $5.115 | -0.008 | -0.2% | $5.115 | $5.115 | $5.115 | 23,852 | |
| $5.123 | -0.016 | -0.3% | $5.123 | $5.123 | $5.123 | 56,964 | |
| $5.139 | -0.07 | -1.3% | $5.139 | $5.139 | $5.139 | 11,534 | |
| $5.209 | +0.062 | +1.2% | $5.209 | $5.209 | $5.209 | 47,409 | |
| $5.147 | +0.03 | +0.6% | $5.147 | $5.147 | $5.147 | 17,532 | |
| $5.117 | -0.016 | -0.3% | $5.117 | $5.117 | $5.117 | 13,620 | |
| $5.133 | -0.079 | -1.5% | $5.133 | $5.133 | $5.133 | 8,072 | |
| $5.212 | +0.034 | +0.7% | $5.212 | $5.212 | $5.212 | 8,439 |
Splits
2 splits since 2014 · OTC:OPHLY · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 3-for-1 | Split | |
| 5-for-1 | Split |
- Ticker
- OTC:OPHLY
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
Consolidated Financial Results for the Second Quarter of Fiscal Year Ending March 31, 2027 (IFRS)
Latest deck · Oct 29, 2026
Q2 FY2027 Earnings Presentation
Earnings · 48 slides
Latest news
Consolidated Financial Results for the Second Quarter of Fiscal Year Ending March 31, 2027 (IFRS)
Oct 28, 2026
Closed $4.66 (-10.0%) on Oct 29, 2026
2nd Quarter of Fiscal Year 2026 (Ending March 31, 2027) (April 1, 2026 to September 30, 2026) Supplementary Materials (Consolidated IFRS)
Oct 28, 2026
Closed $4.66 (-10.0%) on Oct 29, 2026
ONO Pharmaceutical: Pharma Announces an Exclusive License Agreement with Biohaven to Develop and Commercialize IgG Degraders in Japan, South Korea, Taiwan, and ASEAN Countries
Oct 8, 2026
Closed $4.73 (-0.5%) on Oct 8, 2026
Ono Pharma Announces an Exclusive License Agreement with Biohaven to Develop and Commercialize IgG Degraders in Japan, South Korea, Taiwan, and ASEAN
Oct 8, 2026
Closed $4.73 (-0.5%) on Oct 8, 2026
ONO Pharmaceutical: Received Manufacturing and Marketing Approval in Japan for XCOPRI® Tablets for the Treatment of Patients with Partial-onset Seizures, With or Without Secondary Generalized Seizures
Sep 16, 2026
Closed $5.01 (-1.0%) on Sep 16, 2026
Kaneka Ubiquinol™ memenangi nutraingredients Asia Ingredient of the Year: healthspan Award 2026
Sep 8, 2026
Closed $5.12 (-2.4%) on Sep 9, 2026
Issued by another party
OPDIVO® Intravenous Infusion Approved in Taiwan for the Treatment of Resectable Non-Small Cell Lung Cancer with Neoadjuvant OPDIVO in Combination with Chemotherapy Followed by Surgery and Adjuvant Single-Agent OPDIVO
Aug 19, 2026
Closed $5.18 (+1.6%) on Aug 19, 2026
ONO Pharmaceutical: Continues to be Selected for ESG Investment Indexes Adopted by GPIF
Aug 17, 2026
Closed $5.04 (-1.0%) on Aug 17, 2026
Consolidated Financial Results for the First Quarter of Fiscal Year Ending March 31, 2027 (IFRS)
Jul 30, 2026
Closed $4.99 (-2.9%) on Jul 31, 2026
ONO Pharmaceutical Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 30 in the last 12 months · 40 in all · newest Oct 29, 2026 · oldest 2025
- Decks
- 39 decks · latest Oct 29, 2026
Where ONO Pharmaceutical Co., Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Tokyo:4528 小野薬品工業 · Home listing | Tokyo | Japan | JPY |
| OTC:OPHLY · This page | OTC | United States | USD |
| LS Exchange:859650 | LS Exchange | Germany | EUR |
| Lang & Schwarz:859650 | Lang & Schwarz | Germany | EUR |
| BMV:4528N | BMV | Mexico | MXN |
| gettex:ON4 | gettex | Germany | EUR |
| OTC:OPHLF | OTC | United States | USD |
| Dusseldorf:ON4 | Dusseldorf | Germany | EUR |
| Frankfurt:ON4 | Frankfurt | Germany | EUR |
| BIVA:4528N | BIVA | Mexico | MXN |
| gettex:ON40 | gettex | Germany | EUR |
| Lang & Schwarz:A2N6NC | Lang & Schwarz | Germany | EUR |
| Munich:ON4 | Munich | Germany | EUR |
| Munich:ON40 | Munich | Germany | EUR |
| Stuttgart:ON4 | Stuttgart | Germany | EUR |
| Tradegate:ON4 | Tradegate | Germany | EUR |
| Hamburg:ON4 | Hamburg | Germany | EUR |
| Hanover:ON4 | Hanover | Germany | EUR |
Team and board
| Officer | Role |
|---|---|
| Ono Pharmaceutical Co | Corporate Communications |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 FY2027 Earnings Presentation | Earnings | 48 slides | Oct 29, 2026 |
| Q1 FY2027 Earnings Presentation | Earnings | 31 slides | Jul 31, 2026 |
| Investor Day (June 2026) | Investor day | 61 slides | Jun 8, 2026 |
| Investor Day (June 2026) | Investor day | 61 slides | Jun 8, 2026 |
| FY2025 Earnings Presentation | Earnings | 48 slides | May 8, 2026 |
| ESG Presentation (March 2026) | Sustainability | 31 slides | Mar 24, 2026 |
| Investor Day (March 2026) | Investor day | 31 slides | Mar 24, 2026 |
| Q3 FY2025 Earnings Presentation | Earnings | 36 slides | Feb 2, 2026 |
| 44th Annual J.P. Morgan Healthcare Conference (January 2026) | Conference | 30 slides | Jan 14, 2026 |
| Q2 FY2025 Earnings Presentation | Earnings | 54 slides | Oct 30, 2025 |
All 39 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q1 FY2025 Earnings Presentation | Earnings | 37 slides | Aug 1, 2025 |
| Investor Presentation (June 2025) | Investor deck | 9 slides | Jun 19, 2025 |
| Investor Day (June 2025) | Investor day | 15 slides | Jun 4, 2025 |
| Investor Day (May 2025) | Investor day | 39 slides | May 20, 2025 |
| FY2024 Earnings Presentation | Earnings | 44 slides | May 8, 2025 |
| ESG Presentation (March 2025) | Sustainability | 34 slides | Mar 5, 2025 |
| ESG Presentation (March 2025) | Sustainability | 34 slides | Mar 5, 2025 |
| Q3 FY2024 Earnings Presentation | Earnings | 46 slides | Feb 3, 2025 |
| Q2 FY2024 Earnings Presentation | Earnings | 51 slides | Nov 1, 2024 |
| Q1 FY2024 Earnings Presentation | Earnings | 35 slides | Jul 31, 2024 |
| FY2023 Earnings Presentation | Earnings | 40 slides | May 10, 2024 |
| Merger or Acquisition (April 2024) | Merger or acquisition | 27 slides | Apr 30, 2024 |
| Merger or Acquisition (April 2024) | Merger or acquisition | 27 slides | Apr 30, 2024 |
| ESG Presentation (March 2024) | Sustainability | 47 slides | Mar 26, 2024 |
| ESG Presentation (March 2024) | Sustainability | 47 slides | Mar 26, 2024 |
| Technical Presentation (February 2024) | Technical | 65 slides | Feb 22, 2024 |
| Investor Day (February 2024) | Investor day | 65 slides | Feb 22, 2024 |
| ESG Presentation (March 2023) | Sustainability | 48 slides | Mar 28, 2023 |
| ESG Presentation (March 2023) | Sustainability | 48 slides | Mar 28, 2023 |
| Technical Presentation (February 2023) | Technical | 51 slides | Feb 24, 2023 |
| Technical Presentation (February 2023) | Technical | 51 slides | Feb 24, 2023 |
| ESG Presentation (March 2022) | Sustainability | 44 slides | Mar 28, 2022 |
| ESG Presentation (March 2022) | Sustainability | 44 slides | Mar 28, 2022 |
| Technical Presentation (September 2021) | Technical | 31 slides | Sep 7, 2021 |
| Technical Presentation (September 2021) | Technical | 31 slides | Sep 7, 2021 |
| ESG Presentation (March 2021) | Sustainability | 42 slides | Mar 22, 2021 |
| ESG Presentation (March 2021) | Sustainability | 42 slides | Mar 22, 2021 |
| ESG Presentation (March 2020) | Sustainability | 50 slides | Mar 24, 2020 |
| ESG Presentation (March 2020) | Sustainability | 50 slides | Mar 24, 2020 |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Consolidated Financial Results for the Second Quarter of Fiscal Year Ending March 31, 2027 (IFRS) | Oct 28, 2026 | Results | Tokyo Stock Exchange |
| 2nd Quarter of Fiscal Year 2026 (Ending March 31, 2027) (April 1, 2026 to September 30, 2026) Supplementary Materials (Consolidated IFRS) | Oct 28, 2026 | Results | Tokyo Stock Exchange |
| Ono Pharma Announces an Exclusive License Agreement with Biohaven to Develop and Commercialize IgG Degraders in Japan, South Korea, Taiwan, and ASEAN | Oct 8, 2026 | Acquisition or disposal | Tokyo Stock Exchange |
| Consolidated Financial Results for the First Quarter of Fiscal Year Ending March 31, 2027 (IFRS) | Jul 30, 2026 | Results | Tokyo Stock Exchange |
Cap table
Built by 6ix from ONO Pharmaceutical Co., Ltd.’s releases
- Common shares
- 498,692,800
- Fully diluted
- 498,692,800
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 498,692,800 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 498,692,800 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Ono Pharmaceutical Co | Corporate Communications · Since at least May 27, 2026 |
Log in to ask 6ix AI your own questions about ONO Pharmaceutical Co., Ltd.